This is a Darden case study. Various donors and the Novartis Foundation undertook a risk-assessment of how REPSSI could be brought to other African countries both lawfully and efficiently. The original initiative had to be transformed into an organization, and a host country had to be chosen to execute the plan. South Africa, where its effects on children and the HIV/AIDS issue looked the most severe, was selected. By 2006, REPSSI, through its various organizations and institutions throughout sub Saharan Africa, had reached the lives of more than 300,000 orphans. It'd worked at various times with more than 140 aid organizations.
The collaboration had, in particular, been incredibly successful in "transferring best practices in labor management, leadership, and financial abilities." Many of the services businesses and universities provided the NGO were pro bono. The Novartis Foundation's goal was to make REPSSI the "executing agency of choice" for such programs and ensuring long term funding through expanding the donor base.
PUBLICATION DATE: February 27, 2008 PRODUCT #: UV1151-PDF-ENG
This is just an excerpt. This case is about GLOBAL BUSINESS
Related Case Solutions & Analyses:
MCI Communications Corp.: Capital Structure Theory A
Cambridge Technology Partners: Corporate Venturing August 1996
Enron Corp.: Credit Sensitive Notes
Federated Department Stores Inc.: Managing in a Hurricane
Monsantos March into Biotechnology (B)
Micom Caribe (B)
British Airways: Go for It America Promotion (B)
Gordon Cain and the Sterling Group (B)
SAP: The Challenge of Aligning Sourcing and Innovation Strategies
Indonesia: Growth and Stability in a Global Economy
